Company Filing History:
Years Active: 2010
Title: The Innovative Mind of Yip Ping
Introduction
Yip Ping is a notable inventor based in San Diego, California, recognized for his contributions to genetic research and database development. With a focus on enhancing our understanding of genetic markers, his work holds significant implications for medical science and personalized medicine.
Latest Patents
Yip Ping holds a patent titled "Methods for generating databases and databases for identifying polymorphic genetic markers." This invention outlines processes and methods for creating a comprehensive database of genomic samples collected from healthy human donors. The patent provides methodologies for utilizing this database to identify and correlate polymorphic genetic markers associated with various diseases and conditions, representing a pivotal advancement in genetic analysis.
Career Highlights
Currently, Yip Ping is employed at Sequenom, Inc., a company dedicated to innovative molecular diagnostics for prenatal testing and other genetic assessments. His work involves the application of cutting-edge technologies to enhance the understanding of genotypic variations and their implications for human health. His innovative approach and dedication have contributed significantly to the field of genetics.
Collaborations
Throughout his career, Yip has collaborated with distinguished professionals, including Hubert Köster and Andreas Braun, who share his passion for advancing genetic research. These collaborations have fostered a dynamic environment for innovation, blending insights and expertise to drive impactful discoveries in the realm of genetics.
Conclusion
Yip Ping stands out as a significant figure in the field of genetic research, with his patented methodologies paving the way for future advancements. His commitment to innovation at Sequenom, Inc. demonstrates his pivotal role in shaping the future of genomic databases and marker identification, ultimately aiming to improve healthcare outcomes and personalized medicine strategies.